Summary & Overview
HCPCS Q0085: Chemotherapy Administration, Infusion Plus Other Technique(s) per Visit
HCPCS Level II code Q0085 designates a combined chemotherapy administration visit in which medication is delivered by infusion and by an additional technique (for example, subcutaneous, intramuscular, or push) during the same encounter. This code captures the clinical complexity and resource use when multiple administration routes are used in one visit, and it is relevant for national billing, utilization tracking, and care coordination in oncology.
Key payers in scope include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a national overview of how this service is characterized, common payer considerations, and the clinical contexts in which combined administration is documented. The publication provides benchmarks and utilization context where available, summaries of relevant billing practices, and any recent policy or guidance updates affecting multi-route chemotherapy administration.
The piece also covers coding nuances, typical sites of service such as oncology clinics and hospital outpatient infusion centers, and implications for billing workflows. Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Billing Code Overview
HCPCS Level II code Q0085 describes chemotherapy administration by both infusion technique and other technique(s) (e.g., subcutaneous, intramuscular, push), per visit. This service represents a combined administration visit in which a clinician delivers chemotherapy using an infusion method plus one or more additional administration techniques during the same patient encounter.
-
Service type: Combined chemotherapy administration (infusion plus other technique[s])
-
Typical site of service: Oncology clinic, hospital outpatient department, or infusion center where chemotherapy infusions and injectable or push administrations are provided in a single visit.
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A 62-year-old female with stage IIIB breast cancer presents to an outpatient oncology infusion center for a scheduled chemotherapy visit. Her treatment plan includes an intravenous infusion of a cytotoxic agent followed later in the visit by a subcutaneous injection of supportive oncology medication (e.g., a growth factor) and an intramuscular antiemetic administered as a push. The clinical workflow includes patient check-in and assessment by a registered nurse, verification of chemotherapy orders and consents, venous access assessment and securement or port access, administration of the infusion via infusion pump with continuous monitoring, documentation of vital signs and infusion tolerance, subsequent administration of the subcutaneous and intramuscular agents by the same visit, and post-administration observation prior to discharge.
This visit is billed using Q0085 to indicate chemotherapy administration by both infusion technique and other technique(s) during the same encounter. Typical site of service is an outpatient infusion center, oncology clinic, or hospital outpatient department. Relevant team members include medical oncology providers, infusion nurses, pharmacist verifying and preparing agents, and clerical staff for scheduling and billing.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier. | Use when no special modifier applies; default reporting. |